博瑞医药(688166)

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
博瑞生物医药(苏州)股份有限公司
所属行业
医药制造业
上市日期
2019-11-08
注册资本
42310万元
公司概况
博瑞生物医药(苏州)股份有限公司的主营业务是医药中间体、原料药和制剂产品的研发、生产。公司的主要产品是抗病毒、抗真菌、免疫抑制、呼吸系统、抗肿瘤、恩替卡韦、奥司他韦、卡泊芬净、米卡芬净钠。公司先后获得“国家知识产权示范企业”、“国家知识产权优势企业”、“2017年度中国专利优秀奖”、“第十一届中国药学会科学技术奖一等奖”等多项荣誉。

no-quotations

暂不提供行情数据

热议股票

{"pagemeta":{"title":"博瑞医药(688166)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供博瑞医药(688166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"博瑞医药,688166,博瑞医药股票,博瑞医药股票老虎,博瑞医药股票老虎国际,博瑞医药行情,博瑞医药股票行情,博瑞医药股价,博瑞医药股市,博瑞医药股票价格,博瑞医药股票交易,博瑞医药股票购买,博瑞医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"博瑞医药(688166)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供博瑞医药(688166)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"summary","symbol":"688166","data":{"stockData":{"symbol":"688166","market":"SH","secType":"STK","nameCN":"博瑞医药","latestPrice":51.43,"timestamp":1768546801000,"preClose":51.34,"halted":0,"volume":8724520,"delay":0,"changeRate":0.0018,"floatShares":423000000,"shares":423000000,"eps":0.1468,"marketStatus":"已收盘","change":0.09,"latestTime":"01-16 15:00:01","open":51.49,"high":51.95,"low":50.22,"amount":446000000,"amplitude":0.0337,"askPrice":51.43,"askSize":28,"bidPrice":51.4,"bidSize":10,"shortable":0,"etf":0,"ttmEps":0.1468,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768786200000},"marketStatusCode":5,"adr":0,"adjPreClose":51.34,"symbolType":"stock_kcb","openAndCloseTimeList":[[1768527000000,1768534200000],[1768539600000,1768546800000]],"highLimit":56.47,"lowLimit":46.21,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":423103851,"isCdr":false,"pbRate":9.12,"roa":"--","peRate":350.340599,"roe":"2.01%","epsLYR":0.45,"committee":0.316804,"marketValue":21760000000,"turnoverRate":0.0206,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-01-19。","afterMarket":{"amount":0,"volume":0,"close":51.43,"buyVolume":0,"sellVolume":0,"time":1768548837558,"indexStatus":"已收盘 01-16 15:30:00","preClose":51.34},"floatMarketCap":21760000000},"tweetData":null,"newsData":null,"noticeData":{"listData":[],"currentPage":1,"bottom":true},"companyData":{"profile":null,"aProfile":{"ret":0,"serverTime":1768710459436,"stockEarnings":[{"period":"1week","weight":-0.0581},{"period":"1month","weight":0.0475},{"period":"3month","weight":0.0025},{"period":"6month","weight":-0.404},{"period":"1year","weight":0.7114},{"period":"ytd","weight":0.0483}],"compareEarnings":[{"period":"1week","weight":-0.0045},{"period":"1month","weight":0.0598},{"period":"3month","weight":0.0683},{"period":"6month","weight":0.1605},{"period":"1year","weight":0.2676},{"period":"ytd","weight":0.0335}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"博瑞生物医药(苏州)股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"19561人(较上一季度增加104.44%)","perCapita":"21629股","listingDate":"2019-11-08","address":"江苏省苏州市吴中区工业园区星湖街218号纳米科技园C25栋","registeredCapital":"42310万元","survey":"　　博瑞生物医药(苏州)股份有限公司的主营业务是医药中间体、原料药和制剂产品的研发、生产。公司的主要产品是抗病毒、抗真菌、免疫抑制、呼吸系统、抗肿瘤、恩替卡韦、奥司他韦、卡泊芬净、米卡芬净钠。公司先后获得“国家知识产权示范企业”、“国家知识产权优势企业”、“2017年度中国专利优秀奖”、“第十一届中国药学会科学技术奖一等奖”等多项荣誉。","listedPrice":12.71}}}}